Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Ruggero

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Elife|September 4, 2019
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RASMary McMahon, Adrian Contreras, Mikael Holm, et al.
Cancer Research|October 20, 2022
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in MedulloblastomaDuygu Kuzuoglu-Ozturk, Ozlem Aksoy, Christin Schmidt, et al.
Science Translational Medicine|May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancerHao G Nguyen, Crystal S Conn, Yae Kye, et al.
Nature Cell Biology|July 3, 2019
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progressionFeven Tameire, Ioannis I Verginadis, Nektaria Maria Leli, et al.
Nature Cell Biology|July 19, 2019
Author Correction: ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progressionFeven Tameire, Ioannis I Verginadis, Nektaria Maria Leli, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Elife|September 4, 2019
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RASMary McMahon, Adrian Contreras, Mikael Holm, et al.
Cancer Research|October 20, 2022
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in MedulloblastomaDuygu Kuzuoglu-Ozturk, Ozlem Aksoy, Christin Schmidt, et al.
Science Translational Medicine|May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancerHao G Nguyen, Crystal S Conn, Yae Kye, et al.
Nature Cell Biology|July 3, 2019
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progressionFeven Tameire, Ioannis I Verginadis, Nektaria Maria Leli, et al.
Nature Cell Biology|July 19, 2019
Author Correction: ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progressionFeven Tameire, Ioannis I Verginadis, Nektaria Maria Leli, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Pageof 10